Cargando…
Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade
Analyzing mouse tumor models in vivo, human T cells ex vivo, and human lung cancer samples, we provide direct evidence that NR2F6 acts as an immune checkpoint. Genetic ablation of Nr2f6, particularly in combination with established cancer immune checkpoint blockade, efficiently delays tumor progress...
Autores principales: | Klepsch, Victoria, Hermann-Kleiter, Natascha, Do-Dinh, Patricia, Jakic, Bojana, Offermann, Anne, Efremova, Mirjana, Sopper, Sieghart, Rieder, Dietmar, Krogsdam, Anne, Gamerith, Gabriele, Perner, Sven, Tzankov, Alexandar, Trajanoski, Zlatko, Wolf, Dominik, Baier, Gottfried |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5906604/ https://www.ncbi.nlm.nih.gov/pubmed/29670099 http://dx.doi.org/10.1038/s41467-018-04004-2 |
Ejemplares similares
-
Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution
por: Efremova, Mirjana, et al.
Publicado: (2018) -
Orphan Nuclear Receptor NR2F6 Suppresses T Follicular Helper Cell Accumulation through Regulation of IL-21
por: Olson, William J., et al.
Publicado: (2019) -
Loss of the orphan nuclear receptor NR2F6 enhances CD8(+) T-cell memory via IFN-γ
por: Jakic, Bojana, et al.
Publicado: (2021) -
A role for the nuclear receptor NR2F6 in peritoneal B cell homeostasis
por: Olson, William J., et al.
Publicado: (2022) -
Targeting the orphan nuclear receptor NR2F6 in T cells primes tumors for immune checkpoint therapy
por: Klepsch, Victoria, et al.
Publicado: (2020)